Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long‐Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study
Journal of Hepato-Biliary-Pancreatic Sciences · 2025
DOI: 10.1002/jhbp.12181 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Kohei Nakata und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Liver Neoplasms, Hepatectomy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In this study, we investigated the criteria that predict the long‐term survival benefits after surgical resection in patients with pancreatic cancer accompanied by liver oligometastasis.
Methods
In total, 60 patients from 34 high‐volume Japanese centers who underwent surgical resection for liver oligometastasis between 2005 and 2020 were included. Univariate and multivariate methods of survival analyses were performed. All patients were followed up for at least 36 months.
Results
Overall survival (OS) was significantly longer in the preoperative chemotherapy group than in the up‐front surgery group (37.4 vs. 20.4 months, p = 0.001). In the operation with preoperative chemotherapy group, a complete response was observed in eight patients (28.6%). The 1‐, 3‐, and 5‐year OS rates were 92.9%, 50.0%, and 35.7%, respectively. The multivariate analysis showed that low CA19‐9 (< 100 U/mL; HR: 0.25; 95% CI: 0.06–0.96; p = 0.043), low CEA (< 5 U/mL; HR: 0.14; 95% CI: 0.04–0.48; p = 0.002), and resectable (R) or borderline resectable pancreatic cancer invading the portal vein (BR‐PV) status (HR: 0.19; 95% CI: 0.07–0.51; p < 0.001) were positive prognostic factors. The median OS of the patients who met all three criteria was 106.6 months.
Conclusion
Preoperative chemotherapy is essential for the treatment of liver oligometastases. Despite the high recurrence rates, patients who met the specific criteria have a favorable prognosis with liver resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Surgery, Fukuoka University Chikushi Hospital, Chikushino, Japan.
- Department of Hepatobiliary-Pancreatic Surgery, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
- Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Pancreatobiliary Surgery, Kansai Medical University, Osaka, Japan.
ORCID-Profile: Sohei Satoi, Masaaki Hidaka, Shuji Suzuki, Dongha Lee, Yasuro Futagawa, Naoto Gotohda, Junichi Arita, Ken Fukumitsu, Itaru Endo
Zitieren
APA
Nakata, K., Miyasaka, Y., Ishizawa, T., Ohtsuka, M., Mizuma, M., Satoi, S., Hidaka, M., Suzuki, S., Kurahara, H., Kitami, C., Hirano, S., Lee, D., Ko, S., Tahara, M., Yoshioka, I., Date, K., Nagai, K., Honda, G., Mizuno, S., …, & Endo, I. (2025). Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long‐Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12181
Vancouver
Nakata K, Miyasaka Y, Ishizawa T, Ohtsuka M, Mizuma M, Satoi S, et al. Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long‐Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.12181
BibTeX
@article{Nakata2025,
author = {Nakata, Kohei and Miyasaka, Yoshihiro and Ishizawa, Takeaki and Ohtsuka, Masayuki and Mizuma, Masamichi and Satoi, Sohei and Hidaka, Masaaki and Suzuki, Shuji and Kurahara, Hiroshi and Kitami, Chie and Hirano, Satoshi and Lee, Dongha and Ko, Saiho and Tahara, Munenori and Yoshioka, Isaku and Date, Kenjiro and Nagai, Kazuyuki and Honda, Goro and Mizuno, Shugo and Hakamada, Kenichi and Futagawa, Yasuro and Marubashi, Shigeru and Yoshida, Hiroshi and Horiguchi, Akihiko and Hosouchi, Yasuo and Imamura, Masafumi and Gotohda, Naoto and Nagano, Hiroaki and Tani, Masaji and Sudo, Takeshi and Hirashita, Teijiro and Arita, Junichi and Murase, Katsutoshi and Fukumitsu, Ken and Rikiyama, Toshiki and Usuba, Teruyuki and Abe, Toshiya and Nakamura, Masafumi and Endo, Itaru},
title = {Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long‐Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2025},
doi = {10.1002/jhbp.12181}
}
EUVIMED